abstract |
The present invention relates to a pharmaceutical composition comprising a 5HT1 receptor agonist and metoclopramidot in addition to a pharmaceutically acceptable carrier. The pharmaceutical composition can be used to treat migraine in a mammal, including a human, by administering to a mammal a 5HT1 receptor agonist preferably in combination with metoclopramide. SHE |